
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
Several pharmacy groups plan to inform the Federal Trade Commission of their oppositon to the proposed merger of Caremark and AdvancePCS, two of the top four pharmacy benefit managers.






